Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Hematology-Oncology

Reuters reports that Celgene Corp has met their goal in treatment of blood cancer patients with a drug called Revlimid. Revlimid has already been approved for “use in multiple myeloma patients who have failed at least one prior therapy, mantle cell...

Reuters Health • The Doctor's Channel Daily Newscast

Rituximab Safe for Cutaneous B-cell Lymphoma but Relapse Common

NEW YORK (Reuters Health) – A small study indicates that most patients with cutaneous B-cell lymphoma who respond well to rituximab relapse after about two years. On the positive side, the researchers found that rituximab treatment is not associated...
Researchers announced that two people with HIV infections are now apparently virus free since they received bone-marrow transplants for lymphoma and ceased taking antiretrovirals, The New York Times reports. These two cases, both in Boston, mirror...